The test claimed that it offered an alternative to amniocentesis and ultrasound.[10] Gender Mentor claimed that women had many motivations for using the test to learn the sex of their fetuses early in pregnancy, including mental preparation and planning gender-specific purchases, or more controversially, sex-selective abortion.[11][12]
Customers and scientists have questioned the accuracy of the test.[13][14][15] Legal actions were taken against Acu-Gen and their supplier. The lawsuits claimed that Acu-Gen's products do not accurately predict the sex of the baby. In their defense, Acu-Gen stated that ultrasound prediction of the sex of a fetus is not always accurate, and told one family their baby had gender abnormalities.[1][9][14][16][17]
Women were instructed to prick their finger to draw a small amount of blood, which was placed on a card to be sent to Acu-Gen to be analyzed for US$250.[16][18] The kit did not require regulation since it did not diagnose, prevent or treat a disease.[19] The company was not obliged to disclose results of tests.[20]
Acu-Gen listed studies related to detecting fetal blood cells present in maternal circulation, but studies did not refer specifically to the Baby Gender Mentor test.[21] The company claimed that their kit could detect twins.[22]
^Gniady, Jennifer A. (April 1, 2008). "Regulating Direct-to-Consumer Genetic Testing: Protecting the Consumer Without Quashing a Medical Revolution". Fordham Law Review. 76. SSRN1290303.
^Boyce, Nell; Inskeep, Steve (February 27, 2006). "Revisiting the Baby Gender Mentor". National Public Radio. Archived from the original on October 11, 2006. Retrieved January 16, 2007.